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Abstract: Folliculogenesis is a multifaceted process in which follicles mature and produce 
estradiol (E2) and ovulate an oocyte.  β-catenin (CTNNB1) is required as a transcriptional 
co-factor for FSH-simulated E2 production.   In bovine large antral follicles, great r 
concentrations of intra-follicular E2 are associated with increased abundance of CTNNB1 
protein.  Likewise, bovine granulosa cells (GC) in culture, have increased CTNNB1 and 
protein kinase B (AKT) protein, and WNT2 mRNA expression following FSH 
stimulation.  These data indicate that FSH regulates CTNNB1 through the canonical 
WNT or AKT signaling pathways.  AKT and WNT signaling pathways are both capable 
of phosphorylating GSK3-β, a component of the CTNNB1 degradation complex.  
Immunofluorescence FSH time course in bovine GCs from 0 to 48 h was conducted to 
evaluate localization of CTNNB1 from the cell junctions to the cytoplasm and nucleus.  
β-catenin fluorescence into the cytoplasm and nucleus was greatest at 6 h and remained 
the same through 24 h, and was slightly reduced at 48h.  The objective of following 
studies was to elucidate AKT’s role in CTNNB1 accumulation.  Preliminary studies for 
AKT inhibitor (LY294002) and (insulin-like growth factor 1; IGF-I) dose response were 
conducted to determine the optimal response.  Inhibition of the AKT pathway with 
LY294002 was confirmed by the reduction in phosphorylated AKT (pAKT).  Inhibition 
of AKT reduced FSH-mediated CTNNB1 accumulation andsubsequent E2 production in 
bovine GCs.  This suggests that FSH-stimulation of CTNNB1is mediated through the 
AKT signaling pathway.  Another known AKT stimulator, IGF-I, was investigated for its 
ability to regulate CTNNB1.  Insulin-like growth factor 1 increased pAKT compared to 
control and FSH, confirming AKT activation.  Phosphorylated GSK3-β was below 
control and FSH levels for the IGF-I treated GCs, and IGF-I did not stimulate CTNNB1 
accumulation above control.  However, GC production of P4 and E2 were increased as 
expected.  Suggesting IGF-I activation of AKT stimulates activation of other pathways, 
and CTNNB1 may not be required for IGF-I stimulation f steroid production.  
Stimulation with FSH increased accumulation of CTNNB1 protein and E2, and requires 
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The ovary is a dynamic reproductive organ that undergoes numerous changes 
during maturation.  Follicular development or folliculogenesis, is the process in which 
follicles on the ovary grow and mature in response to ndocrine regulation of the 
hypothalamic-pituitary-gonadal axis and local, intraovarian factors.  Endocrine regulation 
of follicular development starts with production of gonadotropin-releasing hormone 
(GnRH) from the hypothalamus.  In the female, the pulsatile release of GnRH and 
subsequent stimulation of the anterior pituitary regulates hormone production and release 
of the gonadotropins, follicle stimulating hormone (FSH) and luteinizing hormone (LH) 
from the anterior pituitary (Nett et al., 2002).  Stimulation of follicle growth, and 
regulation of gene transcription through FSH is important for follicular maturation and 
estradiol production.   Luteinizing hormone initiates steroid hormone production in the 
follicle by regulating theca cell synthesis of testosterone, the precursor of estradiol 
(Carson and Smith, 1986).  Additionally, a surge of LH results in ovulation of the 
dominant follicle and terminal differentiation of the follicle to form the corpus luteum 
(CL).  Together the gonadotropins stimulate steroid hormone production 
(steroidogenesis) in the ovary of the female, by regulating specific cell types.  
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The outer most layer of the follicle is made of theca cells, which contain LH receptors, 
while granulosa cells inside the basement membrane co tain FSH receptors.  Together 
the theca and granulosa cells produce enzymes that cleave cholesterol into steroid 
hormones, and a final product of estradiol (E2) (Carson and Smith, 1986; Gudermann et 
al., 1995).  
Local intraovarian factors, acting in an autocrine or paracrine manner, also play a 
role in regulation of ovarian follicles. Recently, a requirement for β-catenin (CTNNB1) 
has been recognized as a key component for maximal FSH stimulated aromatase and 
estradiol production (Parakh et al., 2006; Hernandez Gifford et al., 2009).  β-catenin is a 
transcriptional co-factor of the wingless-type mouse mammary tumor virus integration 
site (WNT) canonical signaling pathway.  Numerous developmental processes including 
ovarian follicle development in the adult mammal are regulated by locally secreted WNT 
molecules.  The canonical WNT signaling pathway requires regulation of CTNNB1 via a 
degradation complex comprised of glycogen synthase kinase-3 (GSK-β), adenomatous 
polyposis coli (APC), and axin.  Other intraovarian f ctors, including protein kinase B 
(AKT) and insulin-like growth factor 1 (IGF-I), also contribute to follicular development 
and growth during the estrous cycle.  AKT is important for cell survival and inducing 
protein synthesis and is known to interact with WNT signaling pathway.  Additionally, 
IGF-I is recognized for its ability to synergize with gonadotropins to increase 
steroidogenic output (Armstrong and Webb, 1997).   Insulin-like growth factor 1 
stimulates granulosa cell proliferation, differentiation, and cell survival (Davidson et al., 
2002).  Synergy of FSH and IGF-I increases E2, and signals through AKT (Gonzalez-
Robayna et al., 2000).  Furthermore, data from our lab highlight FSH regulation of both 
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CTNNB1 and AKT protein in steroid production in bovine granulosa cells.  These results 
were demonstrated in large dominant bovine follicles with high intrafollicular fluid 
concentrations of E2, which have greater accumulation of CTNNB1, indicating the 
importance of CTNNB1 in bovine folliculogenesis and possibly follicular selection.  
Similarly, cultured granulosa cells treated with FSH had an increased accumulation of 
CTNNB1 and AKT protein, and up-regulation of WNT2 mRNA compared with vehicle 
treated controls (Castanon et al., 2012).  It remains unclear whether FSH regulation of 
CTNNB1 accumulation is through the regulation of AKT or WNT signaling pathways.  






REVIEW OF LITERATURE 
 
 Hypothalamus 
Female ovarian function and male reproductive functio  is initiated through influence of 
the hypothalamus and pituitary (Fink, 1979).  The hypothalamus is located at the base of the brain 
and is a dynamic link between the nervous system and endocrine system.  Normal reproductive 
physiology requires communication and coordination between the hypothalamus, pituitary, and 
gonads.  Signaling interaction of these tissues is called the hypothalamic-pituitary-gonadal axis 
(HPG axis).  The hypothalamus makes up the floor and walls of the third ventricle, and is 
comprised of neuronal cell bodies that produce releasing and inhibiting-hormones (Ingram, 
1939).  Numerous physiological functions are regulated by the hypothalamus including; circadian 
rhythm, heart rate, blood pressure, appetite, body temperature, and reproduction among others. 
The hypothalamus communicates with the pituitary via its axons.  These axons extend to the 
median eminence in the pituitary stock and are a part of neurons located higher in the 
hypothalamus, which release neurohormones into capillary beds of the primary portal plexus.  




The releasing-hormones are immediately transferred via portal vein to the second portal plexus to 
the anterior pituitary.  The hypothalamo-hypophyseal portal system is important because 
releasing-hormones from the hypothalamus are peptides hat have a short half-life and are 
released in minute quantities.  This portal system prevents dilution of the neurohormones by 
directly delivering them to the anterior pituitary.  Production of specific releasing-hormones from 
the hypothalamus occurs as part of feedback regulation.  Positive feedback of estradiol (E2) in the 
female positively influences ovulation of an oocyte as it acts on the pituitary to up-regulate GnRH 
receptors (GnRHr) and enhance responsiveness of GnRH (Reeves et al., 1971; Crowder and Nett, 
1984).  Conversely, the increase E2 for an extended time down regulates GnRHr through negative 
feedback.   
Gonadotrophin-releasing hormone (GnRH) stimulates th  production and release of 
hormones in the anterior pituitary.  Gonadotropin-releasing hormone is a decapeptide produced in 
the ventromedial and arcuate nucleus (tonic center) and surge center (preoptic nucleus) of the 
hypothalamus (Gorski, 1970), which is responsible for initiating the cascade of events that 
regulate the gonads. GnRH is released in a pulsatile f shion to stimulate the production and 
release of hormones in the pituitary (Schneider et al., 2006).  The sequence of GnRH determined 
by (Schally et al., 1971) pyro-Glu1-His2-Trp3 –Ser4 –Tyr5 –Gly6 – Leu7– Arg8 –Pro9 –Gly10 –
NH3.  In response to pulsatile release of GnRH, the pituitary gonadotropes synthesize and release 
FSH and LH into circulation.  Upon binding GnRHr G-protein coupled receptor activates long 
activated calcium channels, causing influx of calcium activation phospholipase C (PLC). 
Subsequently, phosphatidylinositol 4,5- bisphosphate (PIP2) is cleaved by PLC to inositol 
triphosphate (IP3) and diacyl glycerol diffuses to endoplasmic reticulum and binds to IP3 
receptor to cause release of calcium ions into the cytoplasm (Naor, 1990).  Diacylglycerol (DAG) 
remains in the membrane and together DAG and calcium influx leads to the activation of protein 
kinase C (PKC).  Activated PKC phosphorylates and activ tes proteins such as mitogen-activated 
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protein kinase (MAPK).  There are at least 75 genes that are transcribed from GnRH signaling 
through MAPK (Salisbury et al., 2008).  Four of thehallmark genes regulated by GnRH are 
chorionic gonadotropin alpha (Cga), LH β-unit (Lhchb), FSH β-unit (Fshb), and Gnrhr (Salisbury 
et al., 2008).  
As previously mentioned, gonadotropin-releasing hormone’s release is controlled through 
positive and negative feedback systems to result in stimulation of LH and FSH, which regulate 
steroid production in the ovary.  Estradiol increases GnRH and progesterone (P4) decreases 
pulsatile release of GnRH.  In the midluteal phase of the bovine estrous cycle, negative feedback 
of P4 suppresses GnRH release and lowers the expression of G RH mRNA (Weesner et al., 
1993).  Conversely, ovine pituitary cells treated with E2 demonstrate an increase in synthesis and 
insertion of receptors for higher sensitivity to GnRH (Gregg and Nett, 1990).  In bovine cultured 
pituitary cells, an increase of LH is increased at 26 h versus 4 h with in the high dose of E2, 
however the low dose at 26 h is below the 4 h concentrations of LH (Padmanabhan et al., 1978).  
Steroid hormones also influence and alter the releas  p ttern of GnRH that determines which 
gonadotropin, FSH or LH, are produced from the anterior pituitary (Nett et al., 2002).  The 
female brain has both a surge and tonic center, which are developed during sexual differentiation.  
The female brain develops the surge center in the preoptic area, which in the male remains a tonic 
center due of testosterone crossing the blood brain arrier and subsequently being aromatized to 
E2, which prevents formation of the surge center.  The surge center will supply GnRH to 
stimulate the ovulatory surge of luteinizing hormone (LH).  Negative feedback actions of 
increased levels of E2 over a period of time suppress the GnRH frequency while increasing the 
amplitude (Schneider et al., 2006).  Schneider et al. (2006) also demonstrates P4 causes a lower 
frequency of GnRH release.  The dominant follicle producing increasing amounts of E2 stimulates 
GnRH to pulse and increase sensitivity of GnRHr in the anterior pituitary to stimulate LH 
production.  The LH pulse will be high in amplitude from the stimulation of GnRH produced in 
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the surge center in the hypothalamus.  Low amplitude pulses with short intervals from the tonic 
center are regulated by P4 production from the corpus luteum, these pulses of GnRH produce FSH 




The gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are 
heterodimeric glycoprotein hormones produced by gonad tropes in the anterior pituitary.   
Gonadotropins are important in the female to regulate ovarian follicle development (Vale et al., 
1977).  Follicle-stimulating hormone recruits secondary follicles and stimulates maturation of the 
follicle, and the ovulatory surge of LH results in release of the oocyte.  The gonadotropins are 
composed of the same α subunit, and a unique β subunit.  Production and secretion of unique β-
subunit is controlled by estradiol activity that influences the pulsatility of GnRH release (Dalkin 
et al., 1989).   The pulse frequency and amplitude of GnRH determines the regulation of gene 
transcription for FSH and LH β-subunits.  An increase of in GnRH pulse amplitude leads to the 
production to LHβ-subunits and basal pulses lead to the production of FSHβ-subunits.  The 
gonadotropins signal through a 7-transmembrane receptor, which activates heterotrimeric G-
protein (Gudermann et al., 1995; Peirce and Kendrick, 2002).  G-protein coupled receptor 
activates adenylyl cyclase by converting ATP to cAMP (Gudermann et al., 1995; Park et al., 
2005).  Protein kinase A (PKA) directly activates cAMP response element binding protein 
(CREB) to carry out follicular maturation (Hunzicker-Dunn, 1981).  Follicle-stimulating hormone 
also signals through the phosphoinositide 3-kinase (PI3K) pathway that is also stimulated by the 
Gs-protein coupled receptor to subsequently activate protein kinase b (AKT).    
  Follicle-stimulating hormone is necessary to induce maturation of ovarian follicles, in the 
intact animal, resulting in the generation of mature oocytes and production of estrogen 
(Hunzicker-Dunn and Maizels, 2006).  In rodents, FSH pulsatile release occurs approximately 
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every 20 min (Shupnik, 1990).  Receptors for FSH are located exclusively on granulosa cells in 
the ovary and up-regulate genes that drive steroidogenesis and follicular maturity (Carson and 
Smith, 1986).  Granulosa cells acquire FSH receptors (FSHr) as secondary follicles, prior to 
follicular recruitment (Evans and Fortune, 1997).  Granulosa cell proliferation and steroid 
production in growing follicles are stimulated by FSH.  Two hallmark genes of FSH stimulation 
are aromatase and LH receptors.  Aromatase is the enzyme responsible for enzymatically 
converting testosterone into estradiol. The ovarian follicle is the major site for estrogen 
production (Hillier, 1985).  Estradiol 17-β is the most potent estrogen and is at its highest 
concentration during estrus. In response to FSH, granulosa cells acquire LH receptors, which act 
similar to FSHr to activate adenylyl cyclase (Kolena and Channing, 1972).  Up-regulation of LH 
receptor on granulosa cells of dominant follicles aids in the maturation and ovulation of the 
follicle.  Follicle-stimulating hormone secretion is also regulated by ovarian hormones inhibin 
and activin.  Activin up-regulates the FSHβ production by the pituitary (Mason et al., 1989; Weiss 
et al., 1995).  Activin is a glycoprotein produced in the granulosa cells that stimulates FSH 
synthesis and secretion, and aids in cell proliferation, differentiation, and apoptosis.  Female mice 
deficient in activin type II receptor have low FSH levels and are infertile (Matzuk et al., 1995).  
Inhibin is produced by granulosa cells within the developing follicles and suppresses FSH 
synthesis (De Jong and Sharpe, 1976), and may play a p racrine role in the ovary (Hsueh et al., 
1987; Knight et al., 2012).  Inhibin concentrations promote follicular atresia of non-dominant 
follicles and inhibit development of additional follic es (Bicsak et al., 1986).  The inhibitory 
effects of inhibin where demonstrated by vaccinating ewes against this hormone.  Inhibin 
vaccinated ewes, which successfully produced antibody response to inhibin had a yearly increase 
in offspring and ovulation rate (Glencross et al., 1994).  Another regulator of FSH stimulation, 
follistatin, produced in the pituitary, is an activin-binding protein that sequesters activin to lower 
levels of FSH.  Estradiol inhibits the expression of activin lowering the production of FSH.  
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  Luteinizing hormone stimulation of theca cells is required for ovulation of the oocyte 
from the dominant follicle and stimulatory effect of c rpus luteum (CL).  Theca cells produce 
androgen substrates, which will be converted to E2 in the granulosa cell is a key regulator of the 
estrous cycle.  Ovarian steroidogenesis starts in the theca cells when LH binds its receptor and 
subsequently produces testosterone.  Steroid producti n from the ovary requires input from both 
theca and granulosa cells in a model known as two-cell theory of steroidogenesis (Falck, 1959).  
Theca cells contain LH receptors, LH binding causes a gene transcription of enzymes that 
enzymatically cleave cholesterol to testosterone, that is converted E2 by enzyme aromatase in 
granulosa cells containing FSHr (Carson and Smith, 1986).  Antral follicles in which granulosa 
cells have acquired LHCGR, the stimulation of LH matures the oocyte and prepares the cascade 
of genes prepare the dominant follicle for ovulation.  Ovulation is the result of rupturing of a 
mature follicle, which releases antral fluid and eventually the oocyte.  Luteinizing hormone 
signaling induces release of enzymes by granulosa cells leading to follicular rupture and theca 
cell luteinization (Espey, 1974; Brailly et al., 1981).  After ovulation, the follicle differentiates 
into a corpus lutea (CL), which can respond to LH producing P4.  Rahe et al. (1980), 
characterized LH release in bovine estrous cycle by collecting serial blood samples on designated 
days of the estrous cycle to establish pulse frequency and amplitude changes of LH.  Plasma 
concentrations of LH fluctuate in a pulsatile fashion during all phases of the estrous cycle and 
surge to cause ovulation on day 1.  On day three, during the early luteal period; LH pulses exhibit 
low amplitude and high frequency, showing cycle dependent changes in the cow.  During the 
midluteal phase (d 10), the pulses of LH have high amplitude and low frequency, whereas on Day 
18 and 19, LH plasma patterns have both high frequency and high amplitude resulting in the 
preovulatory surge of LH (Rahe et al., 1980).  Nett et al. (2002) showed 75% of stored LH is 
released in response to GnRH to cause the ovulatory surge.  Down regulation of GnRH receptors 
leads to the termination of LH surge as well as depletion of LH (Crowder and Nett, 1984).  After 
ovulation theca and granulosa cells differentiate in to luteal cells that produce P4.  Follicle- 
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stimulating hormone receptors decline after the LH surge, while LH receptors are first 
desensitized and mRNA degraded during the process of luteinization (Camp et al., 1991; Lu et 
al., 1993).  After the LH surge many genes are up regulated including P4 receptor to allow the 
development of a functional corpus lutea (CL) (Park and Mayo, 1991; Natraj and Richards, 
1993).  
 
 Estrous Cycle 
 
The estrous cycle is defined as the period from the onset of heat to the next demonstrated 
heat and relies on hormonal regulation of the HPG axis. The estrous cycle’s distinct phases are 
illustrated and identified by the hormone profiles r presented at different times of the cycle.  The 
bovine estrous cycle ranges from 19-23 d and is divided into two phases, the luteal phase and the 
follicular phase.   In cattle the luteal phase comprises 80% of the estrous cycle and during this 
time the CL is the dominant structure on the ovary.  The remaining 20% of the estrous cycle is the 
follicular phase characterized by a large dominant follicle on the ovary, thus the largest amounts 
of LH and E2 are being produced in this phase (Wettemann et al., 1972).  The luteal and follicular 
phases can each be further divided into two stages, which are defined by hormone profile 
(steroidogenesis) and ovarian structures (folliculogenesis).  The follicular phase last 
approximately three days and eighteen hours and includes proestrus and estrus stages starting d 
17- d 1 of the cycle.  Proestrus is the phase that the CL is regressing, so P4 is declining while the 
dominant follicle is rapidly growing and producing increasing amounts of E2.  The increasing E2 
influences the cow to show heat, this is called estrus.  During estrus, LH will begin to increase in 
pulse frequency and amplitude.  Ovulation occurs in metesrus that last 5 d, and is part of the 
luteal phase.  Diestrus (around 12 d) is also part of the luteal phase, and the main structure on the 
ovary is the CL that produces the characteristic high levels of P4.  Steroidogenesis is a process by 
which the structures on the ovary are influenced by gonadotropins to produce steroid hormones.  
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Interaction of the HPG axis and intraovarian signaling pathways are critical to maintain normal 




  Steroidogenesis in the ovary regulates numerous developmental and physiological 
processes within the body.  Estradiol and P4 are the major female sex hormones, which regulate 
the estrous cycle, and subsequently reproduction.  Development of the ovarian follicle is vital in 
female reproduction as the follicle serves as the major source of steroid hormones.  The precursor 
to all steroid hormones is cholesterol, which is comp sed of lipid 27-carbon (C) structure with 
four hydrocarbon rings.  Steroid hormones are fat soluble and thus easily pass through the plasma 
membrane by simple or facilitated diffusion to then bi d receptors which are located in the 
cytoplasm and nucleus (Mangelsdorf et al., 1995). 
Activation of the enzyme cholesterol esterase, which ydrolyzes cholesterol ester to 
cholesterol, is through the activation of LH binding its receptor on the theca cell.  Inside the theca 
cells, 27- C cholesterol is subjected to enzymes that cleave specified carbons to produce steroid 
hormones.  Cholesterol is delivered to the inner mitochondrial membrane by steroidogenic acute 
regulatory protein (StAR). Up-regulation of StAR is obligatory for steroidogenesis, and is an 
important part of delivering cholesterol to the mitochondria.   Within the mitochondria the first 
enzymatic cleaving of carbons will occur, starting with cytochrome P450 side chain cleavage 
formally Cyp11a1 (Hanukoglu et al., 1990; Amsterdam et al., 1992; Amsterdam and Selvaraj, 
1997).  In the mitochondria of the theca cell and granulosa cell, cholesterol is converted to 
pregnenolone, a 21- C structure, by enzyme P450 side chain cleavage (P450scc; formally 
Cyp11a1).  Theca cells, but not granulosa cells, produce enzyme, 17 beta-hydroxysteroid 
dehydrogenase forms 19- C testosterone from P4.  Testosterone is diffused from theca cells to 
granulosa cells, which make up a majority of the follicular cell composition in the mammalian 
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ovary (Carson and Smith, 1986).  The granulosa cells then convert testosterone to 18-C E2 via 
cytochrome P450 aromatase (Cyp19a1).  Follicle stimulating hormone signals through cAMP to 
regulate transcription of aromatase and subsequent biosynthesis of E2 (Thompson and Siiteri, 
1974).  Increasing amounts of E2 lead to the ovulatory surge and follicle differentiation and 
formation of the CL, as described above. The reproductive system remains poised and ready for 




Before steriodogenesis can occur the follicles must develop and mature into secondary 
follicles.  Development and maturation of ovarian follicles are also associated with changes in 
hormone production coordinated by the HPG axis. The ovary is a key component for 
reproduction because it contains all of the oocytes or females sex cells.  Mammals are born with a 
finite number of oocytes.  During embryonic development, primordial germ cells form and 
migrate from the genital ridge to the gonad.  Once germ cells reach the gonad they are called 
oogonia and develop into clusters of cells called grm line cysts or an oocyte nest (Pepling, 
2006).  In mammals, the developing oocyte is contained within the follicle providing the optimal 
environment for maturation.  Ovarian folliculogenesis i  the process by which primordial follicles 
arise from somatic cells in the ovary and develop into preovulatory follicles for the possibility of 
fertilization (Webb et al., 1992).  Cattle have two to three waves of follicular growth per estrous 
cycle (Savio et al., 1988; Sirois and Fortune, 1988; Ginther et al., 1989).  Folliculogenesis can be 
divided into three distinct stages; recruitment, selection, and dominance.  These stages of 
folliculogenesis are happening in waves of cohort fllicles.  Before recruitment, follicles from the 
primordial pool will grow together at a rapid pace and increase in size.  Primary follicles will then 
degenerate or develop into a secondary/preantral follicle independently of hormones (Cortvrindt 
et al., 1997; Fair, 2003).  The primordial follicle is the most immature stage and is compromised 
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of an oocyte and a single layer of flattened granulosa cells.  The follicles contain an immature 
quiescent egg or oocyte and are suspended in prophase 1 of meiosis.  The granulosa cells become 
cuboidal, reaching the classification of primary follicle (Braw-Tal and Yossefi, 1997; Aerts and 
Bols, 2010).  During the development of primary to secondary follicles, FSH levels are high, 
although early stage follicles develop without hormnal input.  The follicle becomes a secondary 
follicle when there are two or more layers of granulosa cells.  Through classic endocrine 
mechanisms, development of the secondary follicle is influenced by gonadotropins to regulate 
growth (Armstrong and Webb, 1997).  The rapid and continual growth of the oocyte increases 
volume expansion, and the zona pellucida develops between the oocyte and granulosa cells (van 
Wezel and Rodgers, 1996).  Graafian/tertiary follicles have a well-characterized antrum 
containing fluid.  Numerous follicles reach the antr l stage, characterized by the formation of an 
‘antral’ cavity, however as with previous stages, most will under go apoptosis.  During 
recruitment, cohort (6 to 8) of antral follicles responds to FSH and develops LH receptors.  
Following recruitment, the second stage of folliculogenesis is selection a process in which one or 
two select antral follicles are allowed to continue to grow into a Graafian follicle while the rest 
will regress through apoptosis.  During selection, continued growth requires the correct receptor 
type to respond to the hormone stimuli.  Cohorts to the dominant follicle regress in the case of a 
mono-ovulatory species, and only one becomes a dominant follicle.  Through the selection phase, 
FSH concentrations are low, LH concentrations are moderate, and inhibin is rising to further 
decrease FSH concentrations.  The follicles are now pr ducing increased amounts of E2.  The 
final stage is dominance, where the dominant follicle(s) undergo rapid development, while the 
growth of the remainder subordinate follicles are suppressed (Goodman and Hodgen, 1983).  
Follicle development patterns are associated with changes in expression of mRNA encoding 
gonadotropin receptors (Xu et al., 1995) and steroidogenic enzymes to allow selected follicles to 
mature and ovulate in response to the preovulatory LH surge (Armstrong and Webb, 1997).  
Estradiol levels are increasing during selection resulting in increased GnRH sensitivity in the 
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anterior pituitary and subsequently an increase in LH to provide the LH surge for ovulation.  
Follicular fluid of dominant follicles contains higher concentrations of E2, insulin-like growth 
factors-binding protein (IGFBP) protease activity and free IGF, β-catenin (CTNNB1), AKT, and 
lower IGFBP4 concentrations (Mihm et al., 2000; Fortune et al., 2004).  
 
Intraovarian growth factors 
 
There are many intraovarian factors that mediate folliculogenesis and steroidogenesis.  
Two key components for follicular maturation are WNTs and IGF-I.  Follicular fluid from large 
bovine follicles that produced the greatest estradiol had an increase of CTNNB1 and AKT and 
cultured bovine granulosa cells treated with FSH also demonstrated an increase in CTNNB1, 
AKT protein and WNT2 mRNA expression (Castanon et al., 2012).  Accumulation of CTNNB1 
leads to the maximal production of E2.  Both WNT2 and AKT inactivate GSK3-β to allow for this 




Beta-catenin was initially described as a cell-to-cell adhesion molecule, and later 
identified as a transcriptional co-factor (Kemler, 1993; Peifer, 1995).  The β-catenin protein 
(CTNNB1) is 781 amino acids in length in the bovine and is regulated by a degradation complex 
consisting of glycogen synthase kinase-3 (GSK3), adenomatous polyposis coli (APC), and axin 
(Peifer et al., 1994; Zeng et al., 1997; Liu et al., 2002).  The degradation complex marks 
CTNNB1 for ubiquitination and cellular proteosomal machinery then degrades the CTNNB1.   
Disassociation or inactivation of the degradation cmplex leads to CTNNB1 accumulation and 
translocation to the nucleus.  The mechanism by which CTNNB1 crosses into the nucleus is not 
entirely understood.  Current it is understanding is that CTNNB1 binds to the nuclear pore 
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machinery and requires GTP hydrolysis for import (Fagotto et al., 1998).  Nuclear location allows 
for the interaction with nuclear transcription factors to regulate gene transcription.  Accumulation 
of CTNNB1 can be through subsequent WNT or AKT signaling through FSH-stimulation as both 
signaling pathways can deactivate the CTNNB1 degradation complex.  
 
Wingless-Type Mammary Tumor Virus Integration-Site Signaling 
 
The term “WNT” is the fused names of two orthologous genes:  Wg (wingless) in 
Drosophlia segmented polarity gene and of Int-1 (integration), a mouse protooncogene  (Nusse 
and Varmus, 1982).  This is a large family of locally secreted glycoproteins, and there are 
currently 19 known mammalian WNTs (Giles et al., 2003).  These signaling molecules are 
involved in various events during development, such as cell fate specification, cell proliferation, 
differentiation, survival and apoptosis, polarity and migration (Hoppler and Kavanagh, 2007).  
Granulosa cells express specific WNTs, some of which are hormonally regulated during follicle 
development, ovulation, and luteinization (Hsieh et al., 2002; Ricken et al., 2002; Wang et al., 
2010).  Expression of WNT2 mRNA occurs within the follicle at all stages and signal strength in 
granulosa cells of atretic follicles is reduced (Ricken et al., 2002). In bovine granulosa cells, 
WNT2 mRNA and CTNNB1 was increase with FSH stimulation (Castanon et al., 2012) 
 WNT glycoproteins signal through one of 3 pathways; canonical (WNT/β-catenin), 
WNT/Ca2+, and planar cell polarity pathways (Kohn and Moon, 2005; Gordon and Nusse, 2006).  
The canonical pathway uses β-catenin to interact with its transcription factor.  Transduction of 
WNT activates co-receptors, Frizzled (FZD) which are 7 transmembrane G protein-coupled 
receptors and LDL-receptor-related protein (LRP) molecules, leading to phosphorylation of LRP6 
to later recruit axin (Nusse, 2005).  Low density lipoprotein-receptor-related protein 
phosphorylates the protein disheveled (DSH), and DSH recruits axin for disassociation of the β-
catenin degradation complex.  The multi-protein degradation complex marks β-catenin for 
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ubiquitination and is degraded by cellular proteosomal machinery (Giles et al., 2003; Logan and 
Nusse, 2004).  Glycogen synthase kinase-3β (GSK3β), adenomatous polyposis coli (APC), and 
axin comprise the degradation complex (Cadigan and Nusse, 1997).  Once axin is recruited, the 
degradation complex is disassociated allowing β-catenin to accumulate in the nucleus (Mao et al., 
2001).  
 Normal rodent fetal development, sex determination, fertility, and formation of the 
internal and external genitals require WNT, as discovered in a pioneer study through the Wnt4 
knockout mouse (Vainio et al., 1999).  Vainio et al. (1999) knockout Wnt4 demonstrated the 
function of normal female tract development; the mice die within 48 h of birth due to renal 
failure, not allowing observations of sexually mature rodents.  However, the study showed that 
development of the Müllarian ducts, feminization, ad ductile side branching of mammary glands 
is mediated by WNT4.  Mutant knockout Wnt4 mice are partially sex reversed and have 
masculinized proximal sex ducts, resembling epididymal region of the male, being highly 
convoluted, as well as a role in the depletion of oocytes prior to birth.  A recent study using gene 
specific Wnt4 knockout mice (only knocking out Wnt4 in the reproductive tract) show Wnt4 is 
required for steroidogenesis to produce healthy ovarian follicles and cell differentiation to 
produce healthy CL that aids in female fertility (Boyer et al., 2010a).  Wnt4 mutant mice 
demonstrated a decrease in ovary size, with a normal a ount of follicles that developed to the 
secondary follicle stage and the ability to progress to normal follicular development, but with a 
reduced ability to produce E2 (Boyer et al., 2010b).  β-catenin is to allow steroidogenic factor 
1(SF1) to respond to FSH and regulates the biosynthesis of E2 through gene expression of 
Cyp19a1 through functional interactions with SF1 (Parakh et al., 2006).  β-catenin activates 
signaling pathways of FSH and WNT to enhance FSH action and promote preovulatory follicular 






Protein Kinase B (AKT) 
 
Protein kinase B, officially designated AKT, is a kinase important for follicle  
survival, as it blocks apoptosis and induces protein synthesis pathways.  Signaling from  
phoshatidylinositide 3- kinase (PI3K) to activate AKT can be through both G-coupled protein 
receptor and tyrosine kinase receptors.  Activation of AKT though the phosphorylation of Thr-
306 and Ser-437 by phosphoinositide-dependent kinase-1 (PDK1) causes inhibition of pro-
apoptotic factors such as foxhead transcription factors and caspase 9, both are known to mediate 
apoptosis (Cardone et al., 1998; Brunet et al., 1999).  The AKT/PI3K signaling pathway 
activation leads to the interaction with GSK3-β, a member of the β-catenin degradation complex.  
To investigate the AKT/PI3K Signaling pathway, the inhibitor LY294002 is commonly used.  
Protein kinase B is an essential part of FSH-induce aromatase and E2 production (Zeleznik et al., 
2003).  Follicle-stimulating hormone-mediated AKT phosphorylation/activation in rat granulosa 
cells (GC) is detected by 10 min, peaks at 1 h, and is undetectable 4 h after FSH treatment (Alam 
et al., 2004).  FSH activation in granulosa cells leads to the phosphorylation of GSK3-β on Ser-9, 
which subsequently disassociates the β-catenin degradation complex (Fang et al., 2000).  Insulin-
like growth factor 1 and FSH are known stimulators f AKT present in the ovary.  When 
inhibiting the AKT pathway in sheep on the first follicular wave, further follicular growth and E2 
production are inhibited (Ryan et al., 2008).  Studies in bovine GC stimulated with IGF-I and 
PI3-K/AKT inhibitor produced a modest reduction in pERK1/2 in mammary epithelia cells (Mani 
et al., 2010), supporting previous suggestion that cross talk between AKT and MAPK signaling 
pathways exist (Kumar et al., 2008).  The PI3-K pathway was required for protection against 
apoptosis with IGF-I stimulation (Carson and Smith, 1986; Parakh et al., 2006).  Protein kinase B 
has already been demonstrated to be essential component f FSH-induce aromatase and E2 
production in rodents (Zeleznik et al., 2003).  The ability of AKT to inactivate GSK3-β to allow 
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CTNNB1 accumulation indicates AKT’s importance in the regulation of follicle development 
(Wu and Pan, 2010) and has recently been shown in in bovine GC (Castanon et al., 2012). 
 
 
Insulin-like growth factor 1 (IGF-I) 
 
Insulin like growth factor 1 plays leading role through interactions with gonadotropins in 
relation to steroidogenesis and survival response of the follicle (Armstrong and Webb, 1997).  
Production of the peptide IGF-I occurs in important reproductive organs the hypothalamus, 
ovaries, oviducts and uterus (Zhou et al., 1997; Velazquez et al., 2008).  Insulin like growth factor 
1 is one of the numerous intraovarian regulators of follicle development (Kemler, 1993).  The 
most important role of IGF’s appears to be the ability to synergize with gonadotropins and 
amplify the effect of gonadotropins (Adashi et al.,1985; Veldhuis et al., 1986).  Follicular growth 
in bovine can be linked with and steroid production with metabolic status of the animal, making 
IGF-I and insulin key growth factors (Spicer and Echternkamp, 1995).  Cows in a negative 
energy balance will have low concentrations of circulating of IGF-I and/or insulin, and therefore 
the follicular development is compromised (Perks et al., 1999; Webb et al., 2004).  Insulin-like 
growth factor-1’s effects are mediated through type-1 IGF receptor (IGF-IR), which is a 
transmembrane tyrosine kinase receptor, leading to the activation of the PI3K pathways.  Insulin-
like growth factor 1 actives two different pathways, depending on the cell type PI3K and/ or 
MAPK pathway (Butt et al., 1999; Poretsky et al., 1999).  Protein kinase B (AKT), is activated by 
the PI3K pathway, and is an important mediator of pr liferation and cell survival.  The MAPK 
family, extra cellular-regulated kinase (ERK) also regulates proliferation, differentiation, and cell 
survival.   During the selection of the dominant follicle both AKT and ERK signal pathways are 
up regulated in follicles of cattle and sheep (Ryan et al., 2007).  Insulin-like growth factor 1 is 
also known to stimulate proliferation of granulosa cells to enhance steroid production (Spicer and 
Echternkamp, 1995; Davidson et al., 2002).  Follicle-stimulating hormone and IGF-I have shown 
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to act synergistically to enhancing follicular development, in rat GC through AKT (Gonzalez-
Robayna et al., 2000) and bovine GC (Ryan et al., 2008), however, the mechanisms behind the 
interaction remains unclear (Richards et al., 2002; Velazquez et al., 2008).   Estradiol treatment 
can increase IGF-IR in granulosa cells from small bovine follicles (Spicer et al., 1994).  Spicer 
and Aad (2007) and Mani et al. (2010) demonstrate IGF-I synergizes with FSH to increase 
CYP19A1 mRNA.  Genes important for the regulation of steroidogenesis: CYP19A1, CYP11A1 
and HSD3B1 mRNA are up-regulated by IGF-I in bovine granulosa cells, and inhibition of the 
AKT pathway reduces IGF-I stimulated mRNA expression (Mani et al., 2010). Also, FSH and 
IGF-I work synergistically through PI3K-AKT pathways to stimulate steroid production (Mani et 




 Regulation of folliculogenesis and steroidogenesis require a coordinated effort of 
gonadotropins and intraovarian signaling pathways.  The hypothalamic-pituitary-gonadal axis 
regulation of hormones has been identified as controllers of ovarian cyclicity.  However, 
mechanisms of intraovarian signaling pathways stimulated by FSH are not fully understood.  The 
recent findings in our lab using bovine granulosa cells indicate that both AKT protein and WNT2 
mRNA are induced in FSH-stimulated cells.  As CTNNB1 was also increased during FSH-
stimulation, and both AKT and canonical WNT signalig pathways have the ability to regulate 
CTNNB1 accumulation.   The focus of this thesis will be to reveal AKT’s role in the 







AKT IS REQUIRED FOR FSH-STIMULATION  
OF β-CATENIN ACCUMULATION 
 IN BOVINE GRANULOSA CELLS 
 
 
ABSTRACT: Regulation of estradiol (E2) biosynthesis by FSH requires the transcriptional co-
factor beta-catenin (CTNNB1). Increased abundance of CTNNB1 is demonstrated in large antral 
follicles with greatest concentrations of intra-follicular E2.  In bovine granulosa cells (GC), FSH 
increases CTNNB1 and protein kinase B (AKT) protein, a d WNT2 mRNA expression. These 
data indicate FSH regulates CTNNB1 through the canonical WNT or AKT signaling pathways. 
The objective of this study was to elucidate AKT’s role in CTNNB1 accumulation. Bovine GC 
were pre-incubated with AKT inhibitor (LY294002; LY) for 30 min, then cultured with or 
without FSH for 24 h (n = 4).  Total protein was collected for analysis by Western blot.  Relative 
abundance of protein was analyzed using one-way ANOVA procedure of SAS. The AKT 
inhibitor LY reduced total AKT abundance (P = 0.02) and ablated phosphorylated AKT protein 
(P < 0.001).  Inhibition of AKT signaling with LY alone (P = 0.05) or in combination with FSH 
(P = 0.02) reduced CTNNB1 protein compared to FSH-treated GC. Progesterone (P4) media 
concentrations did not differ among treatment groups (P = 0.18).  Inhibition of AKT reduced (P = 
0.02) FSH-mediated E2 production to levels similar to controls.  A subsequ nt study
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was conducted to investigate whether a known AKT stimulator, IGF-I, could also mediate 
CTNNB1 accumulation (n = 3). Bovine GC treated with FSH had greater CTNNB1 compared to 
control and IGF-I groups (P = 0.01).  FSH did not increase P4 (  = 0.46) above controls, 
however, IGF-I alone or in combination with FSH increased (P < 0.001) P4  (161.8 and 185.9 ± 
13 ng/mL, respectively).  Estradiol concentrations were increased in FSH treated GC (140 ± 65 
pg/mL) compared to control treated GC (93 ± 65 pg/mL), and addition of IGF-I alone or in 
combination with FSH increased E2 (280 and 343 ± 65 pg/mL, respectively; P = 0.06).  Data 
demonstrate that AKT is required for FSH-induced accumulation of CTNNB1 and steroid 
synthesis.  IGF-I stimulation of AKT increased steroid synthesis but not CTNNB1 accumulation 
indicating AKT is necessary for FSH-induced accumulation of CTNNB1, and CTNNB1 is not 




The ovary is a dynamic reproductive organ that undergo s numerous changes during 
follicular maturation.  During folliculogenesis ovari n follicles grow and mature in response to 
endocrine regulation of the hypothalamic-pituitary-gonadal axis and local, intraovarian factors 
such as insulin-like growth factor 1 (IGF-I) and AKT.   The pituitary hormone, FSH stimulates 
follicle growth and regulates granulosa cell (GC) gene transcription important for follicular 
maturation and estradiol production.   More recently, the transcriptional cofactor β-catenin 
(CTNNB1) has been recognized as a key component for maximal FSH–stimulated aromatase and 
estradiol production in rodents (Parakh et al., 2006; Hernandez Gifford et al., 2009).  Regulation 
of CTNNB1 occurs via a degradation complex comprised of glycogen synthase kinase-3 (GSK3-
β), adenomatous polyposis coli (APC), and axin.  Recent data from our lab demonstrates that 
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FSH regulates both CTNNB1 and protein kinase B  (AKT) in bovine GC steroid production.  
Large bovine follicles containing high intrafollicular concentrations of estradiol have greater 
accumulation of CTNNB1, indicating the importance of CTNNB1 in folliculogenesis and 
possibly follicular selection (Castanon et al., 201).  Similarly, GCs treated with FSH have 
elevated CTNNB1 and AKT protein, and increased exprssion of WNT2 mRNA (Castanon et al., 
2012).  Follicle-stimulating hormone induced aromatase and estradiol production also relies on 
AKT (Zeleznik et al., 2003).  Furthermore, AKT is important for cell survival and protein 
synthesis, and regulates the deactivation of GSK3-β, a component of the CTNNB1 degradation 
complex.  Insulin-like growth factor 1(IGF-I) is recognized for its ability to synergize with 
gonadotropins to increase steroidogenic output and also signals though the PI3-K/AKT signaling 
pathway (Kemler, 1993; Richards et al., 2002; Mani et al., 2010).  Bovine GC treated with FSH 
and IGF-I synergistically increase CYP19A1 mRNA and signal through the AKT/PI3-K pathway 
(Mani et al., 2010).  Suggesting AKT is important for steroidogenesis and may play a role in 
FSH-stimulated CTNNB1 that is required for E2 production (Hernandez Gifford et al., 2009).  
It remains unclear whether FSH regulation of CTNNB1 accumulation is through the 
regulation of AKT or WNT2 signaling pathways in bovine granulosa cells (GC).  The current 
study will examine AKT’s role in the accumulation CTNNB1.  
 
MATERIALS AND METHODS 
 
Tissue Collection   
 
Bovine ovaries were collected at a local abattoir (Creekstone Farms, Arkansas City, KS) 
from natural, non-pregnant cows and heifers not exposed to implants, ionophores or antibiotics.  
For the first study, 40 pair of bovine ovaries at random stages of the estrous cycle were collected 
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to evaluate FSH regulation of AKT meditated CTNNB1, pAKT, and AKT protein accumulation 
utilizing an AKT inhibitor. A second study was conducted to evaluate the ability other known 
AKT stimulators on CTNNB1 accumulation.  For the second study, 60 pair of bovine ovaries at 
random stages were collected for the evaluation of CTNNB1, pAKT, pGSK3-β, and AKT.  
Ovaries were rinsed with 0.9% saline, followed by a second rinse with 70% ethanol and placed in 
ice cold antibiotic saline solution containing 0.15 M NaCl with 100 U/mL penicillin and 100 
mg/mL streptomycin (Invitrogen, Grand Island, NY) for transport to the laboratory.  Upon 
arrival, antibiotic solution was removed and a replaced with fresh antibiotic saline solution at 
room temperature.  Granulosa cells from small follicles (1 to 5 mm) were isolated by follicular 
fluid aspiration, using a 3-mL syringe fitted with a 20-gauge needle.  The suspension was 
centrifuged at 220 x g for 7 min at 4° C to recover GC.  
 
Granulosa Cell Culture 
 
To determine the role of AKT on CTNNB1 accumulation and subsequent 
steroidogenesis, isolated GCs were cultured using methods previously described (Castanon et al., 
2012).  Follicle size was selected based on indications that follicular recruitment occurs when 
follicles are 4 to 6 mm in diameter in cattle (Savio et al., 1988; Sirois and Fortune, 1988) and 
granulosa cells acquire FSH receptors prior to follicular recruitment (Xu et al., 1995). 
Furthermore, there is no detection of LHCGR mRNA before expression of steroidogenic enzyme 
mRNAs in GC of recruited follicles (Bao et al., 1997).  Isolated GCs were re-suspended and 
washed twice in short-term medium (1:1 mixture of Dulbecco’s modified Eagle medium 
(DMEM) and Ham’s F-12 containing 0.12 mM gentamycin, 2.0 mM glutamine, and 38.5 mM 
sodium bicarbonate obtained from Sigma-Aldrich, St. Louis, MO).  Following the final wash, 
cells were re-suspended in 8 mL of re-suspension mediu  (serum free medium with 2.5 mg/mL 
collagenase and 1 mg/mL DNase, to prevent cell clumping) (Sigma-Aldrich), and cell number 
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and viability were determined by trypan blue exclusion using a hemocytometer.  Dose response 
for LY294002 (Sigma-Aldrich) and IGF-I were conducted in 6-well plates, cells were seeded at 
9.0 x 105 in complete medium (1:1 DMEM and Ham’s F-12 contaiing 10% fetal bovine serum, 
0.12 mM gentamycin, 2.0 mM glutamine, and 38.5 mM sodium bicarbonate).   For experiment 1 
and 2, cells were seeded at a density of 9.3 x 105 in complete medium in 60-mm culture dishes for 
protein.   For hormone analyses 35-mm culture dishes were seeded at 4.0 x 105 in DMEM-F12 
complete medium.  Granulosa cells were incubated for 22 to 26 h at 38.5° in 5% CO2.   Medium 
and unattached cells were removed, wells were washed with warm 1x PBS, and fresh complete 
medium was replaced.  The AKT inhibitor LY294002 (Sigma-Aldrich) dose response study the 
GC at a confluency of 70-85% were washed to remove medium and unattached cells, GC were 
then treated with LY294002 at 10, 20, 30, or 40 µM or dimethyl sulfoxide (DMSO) for 24 h in 
serum-free medium.  The 30 µM dose of LY294002 was chosen based on greatest effect on 
CTNNB1 accumulation with out resulting in cell death, which was seen at the highest dose of 
LY294002.  For experiment (1) GC at 70-85% confluency, were washed to remove medium and 
unattached cells, and GC were then treated with LY294002 (Sigma-Aldrich) at 30 µM or DMSO 
for 30 min in serum-free medium supplemented with 10-7 M testosterone propionate (Sigma-
Aldrich).  Following pretreatment 100 ng/mL of purified human FSH (S1AFP-B-3; National 
Hormone and Peptide Program, National Institutes of Diabetes, Digestive, and Kidney Diseases, 
National Institutes of Health, Bethesda, MD) or vehicle was added directly to the well for 24 h.  
Medium was collected from the 60-mm dishes for steroid analyses and bovine GCs were 
collected in 250 µL of mammalian-protein extraction reagent (M-PER) lysate buffer (Thermo-
Scientific, Rockford, IL), and samples were stored at -20° C until analysis.  For experiment (2) a 
dose response for IGF-I was conducted, at 70% conflue cy, medium and unattached cells were 
removed, and GCs were then treated with 0, 10, 25, 50, or 100 ng/mL of human insulin-like 
growth factor 1 (IGF-I; Sigma-Aldrich).  An initial dose response study provided that at 50 and 
100 ng/mL of IGF-I would maximize the CTNNB1 accumulation above controls, thus a dose of 
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50 ng/mL IGF-I was chosen for treatments.  For experiment 2, GC at a confluency of 70% were 
treated with or without 100 ng/mL of hFSH as previously described by Castanon et al. (2012).  
Directly following hFSH treatment, IGF-I was added at 0 or 50 ng/mL in serum-free medium 
supplemented with 10-7 M testosterone propionate (Sigma-Aldrich) for 24 h.  Bovine GC in 60-
mm were collected in 250 µL of M-PER (Thermo-Scientific), medium was collected from 35-mm 
plates and medium stored at -20˚C until samples were analyzed.  Following a wash with 1x PBS, 
cells were removed from plate 35-mm plate using 1 mL of TrypLE Select (Invitrogen, Grand 
Island, NY).  TrypLE Select was incubated for 5 min at 38.5° in 5% CO2.  Cells were centrifuged 
at 220 x g for 7 min at 4° C.   Cells were reconstituted with 500 µL of 1x PBS.  Granulosa cell 
numbers were determined by trypan blue exclusion using a hemocytometer. 
 
Indirect Immunoflorescence  
 
 
 Indirect immunofluorescence was performed to observe the translocation of CTNNB1 in 
a FSH time course study.  Prior to seeding GCs, cover slips (Fisher Scientific) were flamed and 
treated with Poly-Lysine (Fisher Scientific) to allow attachment of cells to the cover slips. 
Granulosa cells were counted, and seeded at 1.0 x 106 in complete medium.  When cells reached 
70-85% confluency, GC were washed to remove medium and unattached cells, GC were then 
treated with or without 100 ng/mL of purified human FSH in serum-free medium supplemented 
with 10-7 M testosterone propionate (Sigma-Aldrich) prior to immunofluorescence.  Medium was 
collected from the 3-mm dishes for steroid analysis, and washed with PBS.  Bovine granulosa 
cells were fixed at 0 min, 30 min, 3 h, 6 h, 12 h, 18 h 24 h, and 48 h. Bovine GCs were fixed with 
4 % paraformaldehyde for 20 min, fixative was aspirated and wash 3 times with PBS for 5 min 
each on rocking platform.  Next, cells were permeabilized for 5 min with 0.1 % triton x 10 diluted 
in 1x PBS at room temperature.  Cells were subjected to 3 washes with 1x PBS for 5 min each on 
a rocking platform.  Granulosa cells were then incubated in 50 mM ammonium chloride for 15 
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min to quench free aldehyde groups from PFA fixation.   The GC on the cover slips were then 
placed in a humid light-tight box for the remainder of processes.  The GC were blocked in 10% 
goat serum in 1x PBS for 30 min.  Primary antibody a-mouse β-catenin at 1:1000 was pipetted 
directly onto each slip and a piece of parafilm was placed on the slip with the antibody to prevent 
evaporation.  The fixed bovine GCs incubated overnight with the primary antibody.  Bovine GC 
were washed 3 washes with 1x PBS for 5 min each.  Subsequently, keeping the cells in the dark, 
secondary antibody of AlexaFlour 488-goat-α-mouse and fluorecein isothiocyanate (FITC) at a 
concentration of 1:1000 was added directly to the slip and covered with parafilm.  Secondary 
antibody incubated for 2 h at room temp, followed by 3 washes with 1x PBS for 5 min each.  
Bovine GC nuclei were stained with 1 µg/mL DAPI (Invitrogen).  The excess moisture was 
removed.   Cover slips were then mounted to a glass slide by placing cell side down on a drop of 
Vectasheild mounting medium (Vector Labs).  Excess mounting medium was removed and after 
10 -15 min of drying in a dark drawer, clear nail po ish was used to seal the edges.  Slips 




 Total protein lysate was isolated from GC collected in M-PER lysate buffer, according to 
manufacturer’s protocol.  Protein concentrations from primary cultures of bovine GC incubated 
with treatments as described above, were quantified using bicinchoninic acid (BCA) Protein 
Assay Kit (Thermo Scientific, Rockford, IL).  Protein lysates from granulosa cells (10 µg) were 
separated by 10% SDS-PAGE Tris-HCL gels and transferred to Hybond-C Extra nitrocellulose 
membrane (Amersham Bioscience, Piscataway, NJ).  Protein concentrations were chosen on the 
ability to detect the greatest measurable differences (pAKT and pGSK3-β).   Membranes were 
blocked with 5% nonfat dry milk in Tris-buffered saline containing 0.1% Tween-20 (TBST) at 
room temperature for 1 h.  The membrane was incubated in primary rabbit anti-β actin at 
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1:10,000. β-actin was used as loading control for total protein.  The membrane was rocked at 
room temperature for 1 h with secondary antibody, horseradish peroxides-conjugated (HPR) goat 
anti-rabbit (Thermo-Scientific) at a concentration of 1:10,000.  Antibody was detected using 
chemiluminescence with immoblotin detection reagent (Millipore, Billerica, MA) and visualized 
via autoradiograph.  The same process was used for all blots and membrane was probed for 
protein of interest.  β-catenin was detected using primary mouse anti-β-catenin 1: 10,000 (BD 
Transduction Laboratories, San Diego, CA) and secondary goat antimouse 1:10,000 (Thermo-
Scientific).  Rabbit anti-phosphoAKT and rabbit anti-phosophoGSK3-β (Cell Signaling 
Technology, Danvers, MA) final concentration was 1:1000, and HPR-conjugated secondary 
antibody 1:3000 (Thermo-Scientific).  Rabbit anti-AKT concentration was 1:2000 with HPR-
conjugated secondary antibody 1:5000 (Thermo-Scientific).  Relative abundance of proteins was 
quantified using AlphaEaseFC image acquisition system (Alpha Innotech, San Leandro, CA).  
Immunoreactive band intensity was determined in relation to the β-actin loading control.  If no 




Granulosa cell culture medium were analyzed for E2 and P4 by solid phase RIA using 
components of commercial kits manufactured by Siemens Medical Diagnostics Corp. (Los 
Angeles, CA) as previously described (Castanon et al. 2012).  The E2 concentration in samples 
for cell culture medium was determined in 200 µL medium. The specific binding was 62.5%, and 
detection limit (95% of maximum binding) of the assy was 2 pg/mL.  Intra-assay CV for E2 was 
6.5%.  For P4 analysis, samples of GC culture medium were diluted 1:10 in assay buffer and 
assayed at 100 uL. The specific binding for P4 was 58.8%, and detection limit (95% of maximum 








For experiment 1, AKT was inhibited in bovine GCs.   Medium E2 and P4 concentrations 
are representative of entire cell population of 60-mm plates.  Steroid production and protein 
abundance were analyzed using the 1-way ANOVA procedure of SAS (Version 9.3; SAS 
Institute, Inc., Cary, NC).   Experiment 2 bovine GC were treated with AKT stimulators FSH and 
IGF-I.   IGF-I is a mitogen, to account for cell proliferation; steroid production was expressed as 
pg/mL (E2) or ng/mL (P4) per 10
5 GC (after cell culture) or as total (entire cell population in 30-
mm dish) pg/mL (E2) or ng/mL (P4).   Medium steroid concentration and protein abundance for 
experiment 2 were analyzed using the 1-way ANOVA procedure of SAS (Version 9.3; SAS 
Institute, Inc., Cary, NC).   For all experiments significance set was at P = 0.10 and tendency at P 




LY294002 dose response in bovine GCs 
 
 
 The AKT inhibitor LY reduced healthy GC numbers and confluency in all doses tested 
(10, 20, 30, and 40 µM).  The highest doses of 40 µM had low concentrations of protein due to 
the high rate of cell death.  The remaining dose of LY294002 (10, 20, and 30 µM) appeared to 
decrease CTNNB1 accumulation compared to control GCs.  The dose of 30 µM was chosen for 
future experiments, because it had the greatest reduction in CTNNB1 compared to control, 10 and 
20 µM of LY294002, and had reduced cell death (reduced floating cells and an increased 




IGF-I dose response in bovine GCs 
 
 A single dose response study was conducted on GC were treated with IGF-I at 0 
(control), 10, 25, 50, 100 ng/mL of IGF-I based on previous literature.  β-catenin accumulation in 
the low doses (10 and 25 ng/mL) slightly increased, but comparable to control treated GC.  
Insulin-like growth factor 1 at 50 and 100 ng/mL appeared to increase CTNNB1 above control, 
suggesting IGF-I regulation of CTNNB1 (Figure 1B).    
 
FSH Immunofluorescence time course in bovine GCs 
 
 The accumulation and localization of CTNNB1 was evaluated through 
immunofluorescence.   Immunofluorescence allows qualitative analysis of CTNNB1 location.  β-
catenin is highly expressed in cell to cell junctions in the controls.  β-catenin fluorescence in GC 
appears to be increased as early as 3 h after FSH treatment compared to the 0 h control bovine 
GCs.   There appears to be an increase in β-catenin in the cytoplasm and in proximity to the 
nucleus at 3 h and to an even greater extent at 6 h after FSH-stimulation and this remained 
consistent through 24 h.  β-catenin was located in the cell to cell junctions as well as the 
cytoplasm, and in some cases the nucleus of the bovine GCs.   After 48 h of FSH stimulation β-
catenin was reduced with no defined location (Figure 2).  
 
AKT is required for CTNNB1 accumulation 
  
 
 Inhibition of AKT via the AKT inhibitor LY reduced the accumulation of AKT (Figure 
3A) in GC treated with LY alone (P = 0.02) or in combination with FSH (P < 0.01) compared to 
control treated cells.  Granulosa cell accumulation of AKT was not different between control and 
FSH treated groups (P = 0.24; Figure 3A).  Treatment with the AKT inhibitor ablated pAKT, the 
active form of AKT (Figure 3B), compared to control and FSH treated GC (P < 0.01).  Control  
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GC have an increased accumulation of pAKT compared to FSH alone (P < 0.01) when averaged 
across three experiments.  Inhibition of AKT signali g alone reduced β-catenin accumulation 
compared to the non-inhibited groups (P = 0.02; Figure 3C).  No change was detected between 
control as compared to FSH.   Treatment of LY reduc the accumulation of CTNNB1 compared 
to control GC (P = 0.04).  β-catenin accumulation was reduced in AKT inhibited GC treated with 
FSH compared to FSH alone (P = 0.02; Figure 3C).  
 
AKT inhibition reduces steroid production 
 
Steroid production in response to AKT inhibition was determined in medium samples of 
cultured GCs via RIA.  Progesterone production did not differ among the treatment groups (P = 
0.18; Figure 4A). Medium E2 production increased only in FSH-treated cells (P = 0.02).  FSH-
stimulated estradiol (67.7 ± 9.6 ng/mL) production was reduced in AKT inhibited cells and in 
combination with FSH (20.2 ± 9.6 ng/mL) as depicted in Figure 4B.  
 
FSH and IGF-I stimulation increases E2 and P4 production 
 
In experiment 2, known AKT stimulators FSH and IGF-I, were employed to determine 
their ability to facilitate CTNNB1 accumulation and subsequent steroidogenesis in bovine GC 
(Table 1).  Progesterone concentrations increased in medium of bovine GC treated with IGF-I and 
co-incubation with FSH + IGF-I compared to control and FSH (P < 0.01).  A similar pattern was 
demonstrated in medium E2 concentrations as bovine GC treated with FSH in combination with 
IGF-I produced an increase of E2 compared to control and FSH (P = 0.04).  Control (93.2 ± 65.1 
pg/mL) and FSH (140.5 ± 65.1 pg/mL) treated cells did not significantly differ, as depicted in 




FSH increases β-catenin but not pAKT, while IGF-I increase pAKT does not regulate β-
catenin 
 
In experiment 2, AKT accumulation did not differ among treatment groups (P = 0.72; 
Figure 5A).  Granulosa cells treated with FSH, IGF-I, or the combination did not stimulate pAKT 
accumulation (P = 0.32; Figure 5B).  Accumulation of pGSK3-β, was greater in control and FSH-
treated GC than IGF-I treated (P = 01; Figure 5C).  The inactive GSK3-β accumulation is 
decreased by 9 fold in GC treated with FSH in combination with IGF-I compared to control and 
FSH  (P = 0.01).  Total β-catenin protein in bovine GC was increased in FSH compared to control 
and IGF-I (P < 0.01; Figure 5D). The accumulation of β-catenin was comparable between control 
and IGF-I, but IGF-I and FSH-induced accumulation of CTNNB1 is reduced (P = 0.02) 




 The hypothalamic-pituitary-gonadal axis is vital for the regulation of folliculogenesis and 
steriodogenesis.  Follicle-stimulating hormone from the pituitary regulates follicle growth and 
activates intraovarian signaling pathways in GC resulting in CTNNB1 accumulation.  The 
canonical WNT signaling pathway is known for regulating CTNNB1 accumulation, the 
disassociation of the CTNNB1 degradation complex, allows CTNNB1 to interact with 
transcription factors in the nucleus.  β-catenin interacts with transcription factors SF1 to 
transcribe genes, namely Cyp19a1 (Parakh et al., 2006).  Aromatase is required for enzymatic 
conversion of testosterone to E2.  The transcriptional co-activator CTNNB1 is required for 
maximal FSH treatment of Cyp19a1 mRNA expression, and subsequent E2 production in rodents 
(Hernandez Gifford et al., 2009).   The WNT signalig pathway is important in embryonic 
development and for normal follicular development has been demonstrated in rodents (Brunet et 
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al., 1999; Boyer et al., 2010b).  In bovine embryos AKT is important for the inactivation of 
GSK3-β, a reduction in pGSK3-β decreased embryo development and quality, also implicated 
involvement in WNT signaling (Aparicio et al., 2010).  Recent studies in large bovine ovarian 
follicles having the greatest E2, also had an increase in CTNNB1 (Castanon et al., 2012).  Bovine 
GC cultured in the presence of FSH have an increased ccumulation of CTNNB1, as well as AKT 
protein and WNT2 mRNA expression indicating their importance during late follicle development 
(Castanon et al., 2012).  However, the mechanisms of CTNNB1 accumulation are not fully 
understood.  The present study extends these finding to demonstrate that AKT is important for 
downstream activation of FSH activated CTNNB1 accumulation and subsequent E2 production in 
bovine GC, as demonstrated through AKT inhibitor studies.  AKT is needed in the bovine follicle 
to mediate FSH and IGF stimulation of inhibin-A, E2 and P4 secretion (Kemler, 1993).   Follicle-
stimulating hormone activates AKT, which aids in disassociation of the CTNNB1 degradation 
complex.  Data from experiment 1 (Figure 3C) demonstrated that AKT is required for FSH-
mediated CTNNB1 accumulation.  AKT inhibitor LY294002 reduces FSH activation of AKT in 
porcine GC (Johnson et al., 2001).  In the first study, data demonstrated AKT protein was greater 
in control compared to FSH alone; this is likely attributed to DMSO, which serves as the vehicle 
control.  Naito et al. (2005) demonstrated that DMSO was able to increased pAKT and CTNNB1 
in caridomyiod cells.  Stimulation of FSH leads to the phosphorylation of AKT, which 
deactivates GSK3-β through phosphorylation on Ser-9 (Uzbekova et al., 2009).  Deactivation of 
GSK3-β leads to the accumulation of CTNNB1, as GSK3-β is part of the CTNNB1 degradation 
complex.  The CTNNB1 degradation complex is comprised of GSK3-β, APC, and axin (Cadigan 
and Nusse, 1997).  Follicle-stimulating hormone would increase pGSK3-β and subsequently 
CTNNB1 protein accumulation, and E2 concentrations.   In the current study, inhibition of AKT 
via LY294002 ablates pAKT and reduces CTNNB1 accumulation.  AKT inhibited cells had 
reduced FSH-mediated steroid production concentration in the medium.  However, data from 
experiment 2, deactivation of GSK3-β was not increased above controls.   The phosphorylation of 
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GSK3-β is expected to allow CTNNB1 to escape phosphorylation and ubiquitination, which can 
then accumulate and move to the nucleus.  Thus expecting an increase of pGSK3-β in treatment 
groups with increased CTNNB1.  
  Since FSH increases CTNNB1 accumulation in bovine GCs at 24 h (Castanon et al., 
2012), and our data shows AKT is mediating CTNNB1 accumulation down stream of FSH-
stimulation.   The next studies explored another known AKT stimulator IGF-I, to investigate its 
ability to regulate CTNNB1.  Insulin-like growth factor 1 stimulation of CTNNB1 levels were not 
greater than control at 24 h of stimulation, however, in a preliminary IGF-I dose response study 
GC treated with 50 ng/mL of IGF-I appeared to regulate CTNNB1.  Among individual studies, 
IGF-I mediated CTNNB1 protein abundance varied from control (lowly abundant) to FSH 
(highly abundant). The activated form of AKT (pAKT) was not different among any group.  Also, 
IGF-I is not deactivating GSK3-β through the phosphorylation of Ser-9, which can lead to 
CTNNB1 accumulation.  Mani et al. (2010) showed an increase pAKT to AKT ratio 
accumulation in IGF-I-treated GC compared to FSH-treated bovine GC, suggesting IGF-I does 
signal through AKT.  Insulin-like growth factor 1 activation of AKT increases expression of 
steroidogenic genes CYP11A1, HDS3B1, and CYP19A1, which produces enzymes active in the 
conversion of cholesterol to estradiol (Mani et al., 2010).  Follicle-stimulating hormone and IGF-I 
treatments together synergize to increase Cyp19a1 mRNA and E2 production (Spicer and Aad, 
2007; Mani et al., 2010).  In the current study, P4 and E2 for total and per10
5 cell production 
respectively follow the same trend.  Progesterone concentrations in medium were increased in 
IGF-I alone and combined with FSH compared to control and FSH treated GC.  This is expected 
as IGF-I influenced gene transcription of earlier st roidogenic genes that produce P4, compared to 
FSH-stimulation of aromatase that converts androgens to E2 in the GC.    There was also an 
increase in E2 production in the IGF-I treated GC compared to control and FSH treated cells. 
Follicle-stimulating hormone stimulation of CTNNB1 protein (expressed as fold of control) was 
lower in current study than those demonstrated by Castanon et al. (2012).  This suggests that in 
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order for FSH alone to increase aromatase, a minimum CTNNB1 response is required.  Further 
research will be required to verify this suggestion. 
Data for the second study show that pAKT accumulation at 24 h is reduced in FSH 
treated GC compared to control GC, however IGF-I treated GC appear to increase pAKT.  
Activation of AKT through FSH and IGF-I stimulation maybe observed through collecting cells 
at 3 h or after 48h.  The phosphorylation of AKT through IGF-I in bovine GC occurs as early as 5 
min, and pAKT/AKT ratio is greatest at 15 min and the ratio decreases, but remains above the 
initial 5 min activation (Mani et al., 2010).   Ryan nd colleagues (2008) show that sheep GC 
stimulated with FSH accumulated more pAKT than IGF-I alone, however the cells were in 
culture for 144 h, 68 h longer than the present study.  Follicle-stimulating hormone-mediated 
AKT phosphorylation/activation in rat GCs is detected by 10 min, peaks at 1 h, and is 
undetectable 4 h after the FSH treatment and has a biph sic increase (below previous high 
accumulation) around 24-48 (Gonzalez-Robayna et al., 2000; Alam et al., 2004).  In the current 
studies, FSH-stimulation of GCs did not increase total AKT accumulation as previously seen in 
bovine GC at the 24 h time point (Castanon et al., 2012) and sheep GCs (Kemler, 1993).  
Additionally, phosphorylation of GSK3-β did not increase in FSH-stimulated GC as we 
hypothesized; we expected an increase in pGSK3-β accumulation to follow the increase of 
CTNNB1.  There is an increase of pGSK3-β in IGF-I-treated samples compared to FSH and IGF-
I, while the bovine GCs treated in combination of FSH and IGF-I had an increase of CTNNB1 
protein.  A decrease in CTNNB1 accumulation in GC co-incubated in FSH and IGF-I suggests 
the synergy/additive effect of FSH and IGF-I is noten irely through the AKT’s accumulation of 
CTNNB1.  
In conclusion, results from the current study demonstrate that AKT is required for FSH-
induced accumulation of CTNNB1 and steroid synthesis.  Further studies on the ability of IGF-I 
regulate CTNNB1 accumulation in bovine GC are required.  AKT is necessary for FSH-induced 
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accumulation of CTNNB1, and AKT alone is not responsible for FSH and IGF-I induced synergy 





























Figure 1. β-catenin accumulation Western blot (WB) analysis wa performed to measure 
CTNNB1 accumulation.  Effect of AKT inhibitor or stimulator IGF-I on protein in cultured 
bovine granulosa cells (GC) from small follicles (1 to 5 mm).  (A) Bovine GC were pre-treated 
with AKT inhibitor LY294002 at doses of 10, 20, 30, or 40 µM or DMSO for 30 min, and 
incubated for 24 h prior to collection. Using M-PER, total protein was collected.  β-actin was 
used as the loading control for proteins of interest. (B) Granulosa cells were treated with 0, 10, 











      
Figure 2.                                                    
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Figure 2. Effect of FSH treatment intervals on cellular localiz tion of CTNNB1. Bovine 
granulosa cells were fixed and stained at 0, 3, 6, 12, 24, and 48 h after FSH treatments.  β-catenin 
protein is represented in the green florescent (FITC), the middle panel references the cell’s 
nucleus (DAPI), and the third column is a merge of FITC and DAPI to show location and 
movement of CTNNB1 after FSH stimulation.   An increase in CTNNB1 can be observed at 3 h 
of FSH with stronger fluorescence at 6 h of stimulation; at 24 and 48 h CTNNB1 appears reduced 
























Figure 3. Effects of AKT inhibitor LY294002 on bovine granulosa cells (GC) with and without 
FSH stimulation were analyzed using Western blot (WB). Total protein was collected from 
freshly isolated GC from isolated small follicles (1 to 5 mm).  The bovine GC were pre-treated 
with AKT inhibitor LY294002 (30 µM) or vehicle for 30 min, and subsequently treated 100
ng/mL of FSH for 24 h.   Using M-PER a lysate buffer, total protein was collected and β-actin 
was used as the loading control for proteins of interest. (A) Representative WB showing reduced 
accumulation of AKT in LY294002 treated cells. Quantitative analysis of AKT protein 
abundance, indicates successful inhibition of the AKT pathway (P = 0.02).  In GC treated with 
LY alone (P = 0.02) or in combination with FSH (P < 0.01), AKT tended to be reduced compared 
to control. (B) The activated form of AKT (pAKT) protein abundance showed a dramatic 
decrease in LY-treated cells indicating AKT signalig nhibition (P < 0.01).  Lanes with no band 
were assigned zeros, with no difference among treatm nt group; there is no error to report.  (C)
FSH-mediated CTNNB1 accumulation was reduced in the AKT inhibited GC compared to FSH 
treated GC (P = 0.02). Treatment effect of LY compared to control and FSH (P ≤ 0.05 and 0.01) 
respectively.  β-actin served as a loading control.  Columns represent the mean ± SEM, n = 4.  


























Figure 4.  Inhibition of AKT on P4 and E2 production by cultured granulosa cells (GC).  Bovine 
GC pretreated 30 min with LY294002 or vehicle were subsequently treated with 100 ng/mL of 
FSH or vehicle for 24 h prior to medium collection. (A) Progesterone production by bovine GC 
pre-treated 30 min with vehicle or AKT inhibitor LY294002 (30µM) and subsequent 24 h 
treatment with vehicle or FSH (100 ng/mL) was unaffected by treatments (P = 0.18). (B) 
Estradiol production by GC was increased in FSH treated GCs versus AKT inhibited GC 
subsequently treated with FSH, suggesting AKT is important FSH mediated E2 production. 




















Media concentrations of progesterone and estradiol in bovine granulosa cells 
 Progesterone  Estradiol 
  P4, ng/mL P4 /10
5 cells**         E2, pg/mL                                E2/10
5 cells** 
Control  72.7a ± 13.3 26.4 ± 16.1          93.0a ± 65.1         26.7a  ± 21.4 
FSH    87.7a  ± 13.3 24.9 ± 16.1      140.7a ± 65.1         37.8a  ± 21.4  
IGF-I  161.8b  ± 13.3  54.3 ± 16.1       280.2b ± 65.1         76.3ab  ± 21.4  
FSH + IGF-I  185.9b ± 13.3 72.0 ± 16.1       343.5b ± 65.1        115.7b   ± 21.4  
a,b Within a column, means with different subscripts differ P = 0.10,  n = 4 
**Steroid concentration was divided by cell numbers 





































Figure 5.  
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Figure 5.  Effect of FSH and/or IGF-I stimulation on accumulation of AKT, pAKT, pGSK3-β, 
and CTNNB1 protein levels in bovine granulosa cells (GC).  Total protein was collected with 
reagent M-PER from cultured GC from small follicles (1 to 5 mm) after 24 h treatment with  FSH 
(100 ng/mL), IGF-I (50 ng/mL) or co-incubation.  West rn blots (WB) were performed for 
analysis, using β-actin as loading control.  (A) Representative WB of AKT accumulation in 
bovine GC of AKT accumulation after FSH and/or IGF-I treatment of GC (P = 0.72).  (B) 
Representative WB of the activated form of AKT, pAKT accumulation and quantitative analysis 
of pAKT, after FSH and/or IGF-I treatment of GC (P = 0.49).  Number at the bottom of the 
column is pAKT to AKT ratio. (C) Phosphorylation of GSK3-β accumulation was decreased in 
IGF-I treated GC. (D) Accumulation of CTNNB1was increased in FSH treated GC (P = 0.01), 
whereas IGF-I alone did not affect CTNNB1, but reduced the FSH-induced CTNNB1 levels.  
















Figure 6.  β-catenin accumulation is regulated by the AKT signaling and canonical WNT 
signaling pathway.  Follicle-stimulating hormone activates AKT via phosphorylation in 
the disassociation of the CTNNB1 degradation complex a lowing for the accumulation of 
CTNNB1 and transcriptional regulation, which is required for E2 production. WNT 
binding co-receptors Frizzled and LRP leads to the p osphorylation of GSK3-β to 
disassociate the multi-protein complex to allow for CTNNB1 accumulation and 
translocation into the nucleus.  β-catenin within the nucleus interacts with TCF/LEF for 










































SUMMARY AND CONCLUSION 
 
Establishing potential mechanisms involved in bovine fertility is important for cattle 
producers to produce progeny as well as for scientists in pursuit of creating methods to regulate 
the cow’s estrous cycle and establish normal intraovarian activity.   Signaling pathways, pathway 
interactions, and physiological mechanisms in femal reproduction are continually being 
discovered and differences between species is recognized.  Similar among species, FSH 
stimulation of the GC converts testosterone into E2.  β-catenin accumulation through 
FSHmediation is needed for maximal E2 and Cyp19a1 mRNA production in rodents (Hernandez 
Gifford et al., 2009).  Large bovine ovarian follicles with increased E2 also have increased 
production of CTNNB1 and FSH-stimulation of bovine GC increased CTNNB1 and AKT 
proteins and Wnt2 mRNA (Castanon et al., 2012). 
 The WNT and AKT signaling pathway are both known for the ability to phosphorylate 
GSK3-β, rendering the CTNNB1 complex inactive.  β-catenin degradation complex is comprised 
of GSK3-β, APC, and axin.  The phosphorylation of GSK3-β on Ser 9 makes the protein inactive, 
and disassociates the multi-protein complex.  Inactiv ting the CTNNB1 degradation complex 
through FSH activating AKT signaling, in turn phosphorylating GSK3-β, as does WNT signaling 
through co-receptors Frizzled and LRP.   Both AKT and WNT signaling pathways increase 
cytoplasmic CTNNB1 and translocation to the nucleus.  Accumulation of CTNNB1 in the 
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nucleus is regulated by CTNNB1 escaping phosphorylation by the multi-protein degradation 
complex.  The accumulation of CTNNB1 in the nucleus allows interaction with transcription 
factors (TCF/LEF and SF1) and subsequent gene transcription. The focus of these studies was to 
investigate AKT’s role in CTNNB1 accumulation.   
 Our data shows normal production of E2 and accumulation of CTNNB1 requires the AKT 
signaling pathway.  Inhibition of AKT using LY294002 reduces FSH-mediated CTNNB1 
accumulation and production of E2.  These data show for the first time that AKT is necessary for 
FSH-mediated accumulation of CTNNB1.  IGF-I, another AKT stimulator may increase 
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